SCHEMBL21385481

SCHEMBL21385481

CC(C)(CCC(C)(C)c1cncs1)c1ccnnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25490213 0.79 KIF11 (0.35) —
SCHEMBL19252595 0.73 CNR2 (0.33) —
SCHEMBL19646362 0.73 HDAC8 (0.32) —
SCHEMBL18826992 0.72 — —
SCHEMBL21482041 0.71 — —
SCHEMBL19738679 0.70 CNR2 (0.40) —
SCHEMBL24862786 0.70 CNR1 (0.31) —
SCHEMBL22023780 0.69 CNR2 (0.45) —
SCHEMBL23634131 0.69 HDAC8 (0.34) —
SCHEMBL22328432 0.69 NPC1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10420753-B2 Combination therapies for treatment of spinal muscular atrophy INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2019-09-24 — — US disclosed
Send feedback